...
首页> 外文期刊>Clinical advances in hematology & oncology: H&O >The hypercoagulability of intravenous immunoglobulin.
【24h】

The hypercoagulability of intravenous immunoglobulin.

机译:静脉的血凝过快免疫球蛋白。

获取原文
获取原文并翻译 | 示例
           

摘要

H&O What is intravenous immunoglobulin? MM Intravenous immunoglobulin (IVIG) is a solution of human plasma-derived immunoglobulin containing an extensive range of immune antibodies that may protect against human pathogens or antigens. It has been in use for more than 2 decades, for conditions such as idiopathic thrombocytopenic purpura, chronic lymphocytic leukemia, and HIV infection. The number of diseases that are being treated with IVIG continues to increase (Table 1). Shortly after the introduction of IVIG agents, they were found to be effective in the treatment of autoimmune and inflammatory disorders. IVIG can sometimes achieve a cure in patients who do not respond to first-line therapies.
机译:氢和氧静脉注射免疫球蛋白是什么?静脉注射免疫球蛋白(丙种球蛋白)是一个解决方案人类plasma-derived免疫球蛋白含有一个广泛的免疫抗体防止人类病原体或抗原。已经使用超过2年了,对吗特发性血小板减少性等条件紫癜、慢性淋巴细胞白血病和艾滋病病毒感染。用丙种球蛋白治疗继续增加(表1)。之后不久的丙种球蛋白代理,他们被发现是有效的治疗自身免疫和炎症障碍。病人不应对一线疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号